Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.

Verdejo-García AJ, López-Torrecillas F, Aguilar de Arcos F, Pérez-García M.

Addict Behav. 2005 Jan;30(1):89-101.

PMID:
15561451
2.

Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.

Fernández-Serrano MJ, Pérez-García M, Schmidt Río-Valle J, Verdejo-García A.

J Psychopharmacol. 2010 Sep;24(9):1317-32. doi: 10.1177/0269881109349841. Epub 2009 Dec 9.

PMID:
20007413
3.
4.

Drug-related decrease in neuropsychological functions of abstinent drug users.

van Holst RJ, Schilt T.

Curr Drug Abuse Rev. 2011 Mar;4(1):42-56. Review.

PMID:
21466500
5.

[The impact exerted by the severity of recreational drug abuse on the different components of the executive function].

Verdejo A, Orozco-Giménez C, Meersmans Sánchez-Jofré M, Aguilar de Arcos F, Pérez-García M.

Rev Neurol. 2004 Jun 16-30;38(12):1109-16. Spanish.

6.

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.

J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21.

PMID:
18208910
7.

Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.

Fernández-Serrano MJ, Lozano O, Pérez-García M, Verdejo-García A.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):57-64. doi: 10.1016/j.drugalcdep.2009.12.007. Epub 2010 Jan 12.

PMID:
20064697
8.

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.

Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):819-27.

PMID:
12921915
9.

Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.

Verdejo A, Toribio I, Orozco C, Puente KL, Pérez-García M.

Drug Alcohol Depend. 2005 Jun 1;78(3):283-8. Epub 2004 Dec 23.

PMID:
15893159
10.

Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities.

Fernández-Serrano MJ, Pérez-García M, Perales JC, Verdejo-García A.

Eur J Pharmacol. 2010 Jan 10;626(1):104-12. doi: 10.1016/j.ejphar.2009.10.019. Epub 2009 Oct 15.

PMID:
19836375
11.

Verbal working memory deficits in current and previous users of MDMA.

Wareing M, Fisk JE, Murphy P, Montgomery C.

Hum Psychopharmacol. 2004 Jun;19(4):225-34.

PMID:
15181650
12.

Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.

Lamers CT, Bechara A, Rizzo M, Ramaekers JG.

J Psychopharmacol. 2006 Mar;20(2):302-11.

PMID:
16510488
13.
14.

Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?

Piechatzek M, Indlekofer F, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.

Hum Psychopharmacol. 2009 Dec;24(8):650-65. doi: 10.1002/hup.1069.

PMID:
19946940
15.

Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.

Verdejo-García A, Pérez-García M.

Psychopharmacology (Berl). 2007 Mar;190(4):517-30. Epub 2006 Nov 29.

PMID:
17136401
16.

Effects of executive impairments on maladaptive explanatory styles in substance abusers: clinical implications.

García AV, Torrecillas FL, de Arcos FA, García MP.

Arch Clin Neuropsychol. 2005 Jan;20(1):67-80.

17.

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.

J Psychopharmacol. 2006 May;20(3):373-84.

PMID:
16574711
18.

Supplemental Content

Support Center